Spots Global Cancer Trial Database for serplulimab, albumin paclitaxel, carboplatin auc=5, neoadjuvant therapy
Every month we try and update this database with for serplulimab, albumin paclitaxel, carboplatin auc=5, neoadjuvant therapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma | NCT05659251 | Esophageal Squa... Neoadjuvant The... | Serplulimab, Al... Esophagectomy sample | 18 Years - 75 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University |